FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
114,331,829
Total 13F shares
80,446,666
Share change
+1,160,185
Total reported value
$101,355,707
Put/Call ratio
38%
Price per share
$1.26
Number of holders
138
Value change
+$1,878,808
Number of buys
63
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2025

As of 30 Sep 2025, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,446,666 shares. The largest 10 holders included Redmile Group, LLC, BlackRock, Inc., VANGUARD GROUP INC, Wilshire Advisors LLC, JOHNSON & JOHNSON, ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Vestal Point Capital, LP, STATE STREET CORP, and DIMENSIONAL FUND ADVISORS LP. This page lists 138 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.